Apple Inc shares plunged more than 9% on Friday after the technology giant reported fiscal third-quarter results that beat earnings estimates but delivered fourth-quarter revenue guidance that fell short of analyst expectations. Despite the sell-off in Apple, broader U.S. equity markets traded higher midway through the session, with the Dow Jones Industrial Average gaining approximately 200 points to close at 52,406.69, up 0.38%. The S&P 500 rose 0.22% to 7,453.96, and the NASDAQ Composite increased 0.25% to 25,184.43.

The divergence in Apple’s performance highlights investor sensitivity to forward-looking metrics even when current-period profitability exceeds forecasts. While the company demonstrated operational strength in the quarter, the miss in future sales projections triggered a significant market reaction, underscoring the premium investors place on growth visibility in the tech sector.

Apple Q3 Financial Performance

Apple reported fiscal third-quarter revenue of $109.42 billion, surpassing analyst estimates of $108.65 billion. The Cupertino-based company also posted earnings per share (EPS) of $2.02 for the quarter, beating the consensus estimate of $1.89 per share. However, the positive current-period results were overshadowed by cautious forward guidance.

Apple stated it sees fourth-quarter sales ranging from $111.688 billion to $113.737 billion, compared to analyst estimates of $114.840 billion. This guidance miss suggests potential headwinds in upcoming sales cycles, prompting the sharp decline in share price despite the quarterly beat.

Market Movers and Sector Performance

Consumer discretionary shares led the market rally, jumping by 5.6% on Friday. In contrast, materials stocks declined by 2.7%. Several individual equities saw significant volatility based on earnings reports and clinical trial outcomes.

Equities Trading Up:

• Newell Brands Inc: Shares surged 22% to $6.29 after reporting better-than-expected second-quarter financial results and raising its FY26 guidance.
• AXT Inc: Stock jumped 20% to $55.88 following strong second-quarter results and robust third-quarter guidance.
• Forum Energy Technologies Inc: Shares gained 20% to $61.43 after beating second-quarter expectations and raising FY26 sales guidance above estimates.

Equities Trading Down:

• Karyopharm Therapeutics Inc: Shares dropped 68% to $2.27 after Phase 3 XPORT-EC-042 trial topline results failed to meet the primary endpoint of progression-free survival.
• Myriad Genetics Inc: Stock fell 42% to $3.10 due to worse-than-expected second-quarter results and lowered FY2026 sales guidance.
• Roblox Corp: Shares declined 29% to $34.32 following second-quarter results.

Global Markets and Commodities

Asian markets closed higher on Friday, with Japan’s Nikkei 225 surging 4.03%. China’s Shanghai Composite gained 0.72%, Hong Kong’s Hang Seng index rose 0.01%, and India’s BSE Sensex increased 0.21%. European shares were mostly lower; the STOXX 600 slipped 0.1%, Germany’s DAX declined 0.1%, Spain’s IBEX 35 fell 0.1%, and London’s FTSE 100 dropped 0.2%. France’s CAC 40 was an exception, gaining 0.3%.

In commodities, crude oil prices rose 1% to $84.39. Precious metals faced downward pressure, with gold trading down 1.5% at $4,098.30 and silver falling 2.2% to $57.67. Copper prices dipped 0.4% to $6.4495.

Economic Indicators

U.S. economic data showed mixed signals. Employment costs increased by 0.9% in the second quarter, exceeding market estimates of a 0.8% rise. Meanwhile, consumer confidence improved, with the University of Michigan’s consumer sentiment index rising to 55.2 in July, up from a preliminary reading of 54.0.